期刊文献+

循环EPCs CD34^+水平与高血压病患者心血管危险因素的关系 被引量:2

Relationship between Circulating EPCs CD34^+ Cells and Cardiovascular Risk in Hypertension
下载PDF
导出
摘要 目的探讨能否将循环内皮祖细胞(EPCs)CD34+水平作为评价高血压病患者心血管危险度的标志。方法高血压病患者组62例,对照组20例。高血压病患者采用Framingham心血管危险因素积分分层心血管危险因素,分为低危组18例,中危组14例,高危组17例,极高危组13例。作外周血循环EPCs CD34+水平与Framingham心血管危险因素积分的相关性分析。结果各研究组高血压病患者外周循环EPCs CD34+水平随着其心血管危险程度的增加,逐步下降,各组间比较有统计学意义(P<0.05)。EPCs CD34+水平与Framingham心血管危险因素积分呈负相关关系(r=-0.875,P<0.01)。结论高血压病患者循环EPCs CD34+水平下降与心血管危险因素有显著的相关性。循环EPCs CD34+水平可以作为高血压病患者心血管危险度的标志。 Objective To evaluate whether the variations in the number of circulating endothelial progenitor cells(EPCs)CD34^+ could be presented as the maker of cardiovascular risk in patients (pts) with hypertension. Methods Sixty - two pts with hypertension and 20 healthy controls were collected. Pts stratified by cardiovascular risk factors according to Framingham risk factors score were divided into lowrisk group (n=18),mid- risk group (n=14), high- risk group (n= 17) and much- high- risk group (n = 13). The level of peripheral circulating EPCs CD34^+ was measured. The relationships between circulating EPCs CD34^+ and Framingham cardiovascular risk factors was analyzed. Results The level of peripheral circulating EPCs CD34^+ was significantly lower in pts with hypertension than that in control group (P〈0.05), and CD34^+ cells were inversely correlated with cardiovascular risks. There was a negative correlation between the level of circulating EPCs CD34^+ and Framingham cardiovascular risk factors(r= -0. 875,P〈0.01). Conclusion The level of peripheral circulating EPCs CD34^+ cells was significantly reduced with the increase of score of cardio vascular risk factors . This study demonstrated that the level of circulating EPCs was a predictor of cardiovascular risk in pts with hypertension.
出处 《中西医结合心脑血管病杂志》 2009年第1期19-20,共2页 Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
基金 广州市医药卫生科技基金项目(No.2007-YB-173) 广东省第一批科学事业费科技基金项目(No.2007B031509010)
关键词 内皮祖细胞 CD34+ Framingham心血管危险因素积分 高血压病 endothelial progenitor cells CD34^+ Framingham risk factors score hypertension
  • 相关文献

参考文献7

  • 1Brixius K, Funcke F,Grat C, et al. Endothelial progenitor cells: A new target for the prevention of cardiovascular diseases[J].Eur J Carelioves Prev Rehabil,2006,13(5):708- 710.
  • 2Werner N,Junk S, Laufs U,et al. Intravenous transfusion of endothelial progenitor cells reduces neointima formati.O~ after vascular injury[J].Circ Res, 2003,93 : e17 - e24.
  • 3Suzuki T, Nishida M, Futami S, et al. Neoendothelialization after peripheral blood stem cell transplantation in humans:A case report of a tokaimura nuclear accident victim[J].Cardiovasc Res, 2003, 58:487 -492.
  • 4Murayama T, Tepper OM, Silver M, et al. Determination of bone marrow- derived endothelial progenitor cell significance in anglogenie growth factor - induced neovascularization in vivo[J].Exp Hematol, 2002,30 : 967 - 972.
  • 5Imanisihi T, Moriwaki C, Hano T,et a l. Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension[J].J Hypertens,2005,23 (10) :1831 - 1837.
  • 6蓝景生,黄照河,潘兴寿,王小庆,罗初凡,杨燕华.循环中内皮祖细胞与原发性高血压的关系[J].右江民族医学院学报,2006,28(6):916-918. 被引量:2
  • 7Hill JM.Zalos G, Halcox JP,et al. Circulating endolhelial progenitor cell vascular function and cardiovascular risk[J]. N Engl J Med, 2003,2 (348):593-600.

二级参考文献10

  • 1Urbich C,Dimmeler S.Risk factors for coronary artery disease,circulating endothelial progenitor cells,and the role of HMG-CoA reductase inhibitors[J].Kidney Int,2005,67(5):1672-6.
  • 2Steiner S,Schaller G,Puttinger H,et al.History of cardiovascular disease is associated with endothelial progenitor cells in peritoneal dialysis patients[J].Am J Kidney Dis,2005,46(3):520-8.
  • 3Loomans CJ,DAO HH,van Zonneveld AJ,et al.Is endothelial progenitor cell dysfunction involved in altered angiogenic processes in patients with hypertension[J].Curr Hypertens Rep,2004,6(1):51-4.
  • 4Kalka C,Masuda H,Takahashi T,et al.Transplantation of ex vivo expanded endothelial progenitor cells for therapeuticneovascularization[J].Proc Natl Acad Sci USA,2000,97(7):3422-3427.
  • 5Vasa M,Fichtlscherer S,Adler K,et al.Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease[J].Circulation,2001,103(24):2885-2890.
  • 6Hill JM,Zalos G,Halcox JP,et al.Circulating endothelialprogenitor cells,vascular function,and cardiovascular risk[J].N EnglJ Med,2003,348(7):593-600.
  • 7Walter DH,Rittig K,Bahlmann FH,et al.Statin therapy accelerates reendothelialization:a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells[J].Circulation,2002,105(25):3017-3024.
  • 8Imanisihi T,Moriwaki C,Hano T,et al.Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension[J].J Hypertens,2005,23(10):1831-1837.
  • 9Zhao YD,Courtman DM,Deng Y,et al.Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells:efficacy of combined cell and eNOS gene therapy in established disease[J].Circ Res,2005,96(4):442-50.
  • 10Touyz RM,Schiffrin EL.Reactive oxygen species in vascular biology:implications in hypertension[J].Histochem Cell Biol,2004,122(4):339-352.

共引文献1

同被引文献14

  • 1蓝景生,黄照河,潘兴寿,王小庆,罗初凡,杨燕华.循环中内皮祖细胞与原发性高血压的关系[J].右江民族医学院学报,2006,28(6):916-918. 被引量:2
  • 2崔斌,黄岚,武晓静,周音频,张艺.内皮祖细胞移植对血管内膜修复的影响[J].中国病理生理杂志,2007,23(4):625-628. 被引量:20
  • 3Brixius K, Funcke F, Grat C, et al. Endothelial progenitor cells: A new target for the prevention of cardiovascular diseases [J]. Eur J Carelioves Prev Rehabil, 2006,13(5):705-710.
  • 4Bompais H, Chagraoui J, Canron X, et al. Human endothelial cells derived from circulating progenitors display specific functional properties compared with mature vessel wall endothelial cells [J]. Blood, 2004, 103:2577-2584.
  • 5Whittaker A, Moore JS, Vasa NM, et al. Evidence for genetic regulation of endothelial progenitor cells and their role as biological markers of atherosclerotic susceptibility[J]. EurHeart J, 2008,29(3): 332-338.
  • 6Imanisihi T, Moriwaki C, Hano T,et al.Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patiems with essential hypertension [J]. J Hypertens, 2005,23 (10): 1831-1837.
  • 7Pietroa D, Maurizioa D, Paola V, et al. Endothelial progenitor cells in patients with essential hypertension [J]. Hypertension, 2007,25 (1): 127-132.
  • 8Delva P, Degan M, Vallerio P, et al. Endothelial progenitor cells in patients with essential hypertension [J]. J Hypertens, 2007,25: 127-132.
  • 9Toshio I, TakuzoH, lchiroN. Angiotensin II accelerates endothelial progenitor cell senescence through induction ofoxidative stress [J]. JHypertens, 2005, 23 (1): 97-104.
  • 10张文斌,宋筱筱,方英,傅国胜.血管内皮生长因子对外周血内皮祖细胞功能的影响[J].中国病理生理杂志,2007,23(10):1896-1899. 被引量:11

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部